The global spine biologics market is expected to grow at a 4.4 percent compound annual growth rate to reach more than $2.6 billion by 2022, according to a Market Research Engine report.
Here are 17 key market players:
1. DePuy Spine
2. Precision Spine
3. Medtronic
4. Stryker
5. Smith & Nephew
6. Orthovita
7. Zimmer Spine
8. K2M
9. NuVasive
10. Arthrex
11. DMP Spine
12. Alphatec Spine
13. Orthofix
14. RTI Surgical
15. Wright Medical Technology
16. Cesca Therapeutics
17. Lattice Biologics